Lexicon Pharmaceuticals | LXRX - Market Capitalization


Lexicon Pharmaceuticals reported $568.8M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
AstraZeneca USD 178.35B 111.64B Aug/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Illumina USD 26.71B 8.84B Jun/2026
Insmed USD 35.3B 1.82B Mar/2026
J&J USD 611.36B 32.21B Jun/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
MacroGenics USD 184M 82M Mar/2026
MannKind USD 757M 984M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Ultragenyx Pharmaceutical USD 2.05B 9M Aug/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024